(MedPage Today) — The FDA has approved a reformulated version of ranitidine (Zantac), more than 5 years after requesting the antacid be pulled from shelves over concerns that it could break down into a carcinogen.
Federal regulators announced…
Webinar on allied health and nursing to be held on May 11
With the growing demand for quality healthcare services, allied health and nursing professionals are playing an increasingly significant role in...






